Two symposia beginning at 2:00 p.m. CT on Friday will review the latest findings and new treatment strategies to mitigate cardiac and kidney disease in diabetes. “Our patients cross the boundaries between cardiology and diabetes, and we have to do the same to co-manage them more effectively,” said Suzanne V. Arnold, MD, MHA.
Don’t miss: Companion sessions will explore new approaches for reducing ASCVD risk in diabetes, the role of kidney in ASCVD
